nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivastigmine—Appetite absent—Metformin—polycystic ovary syndrome	0.0252	0.0436	CcSEcCtD
Rivastigmine—Body temperature decreased—Metformin—polycystic ovary syndrome	0.0224	0.0387	CcSEcCtD
Rivastigmine—Hypothermia—Metformin—polycystic ovary syndrome	0.0224	0.0387	CcSEcCtD
Rivastigmine—Nail disorder—Metformin—polycystic ovary syndrome	0.0194	0.0335	CcSEcCtD
Rivastigmine—Fungal infection—Metformin—polycystic ovary syndrome	0.0163	0.0281	CcSEcCtD
Rivastigmine—Rigors—Metformin—polycystic ovary syndrome	0.0154	0.0266	CcSEcCtD
Rivastigmine—Neuropathy—Metformin—polycystic ovary syndrome	0.0118	0.0204	CcSEcCtD
Rivastigmine—Ear pain—Metformin—polycystic ovary syndrome	0.0107	0.0185	CcSEcCtD
Rivastigmine—Injury—Metformin—polycystic ovary syndrome	0.00991	0.0171	CcSEcCtD
Rivastigmine—Renal impairment—Metformin—polycystic ovary syndrome	0.00957	0.0166	CcSEcCtD
Rivastigmine—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.00934	0.0161	CcSEcCtD
Rivastigmine—Pain in extremity—Metformin—polycystic ovary syndrome	0.00911	0.0158	CcSEcCtD
Rivastigmine—Migraine—Metformin—polycystic ovary syndrome	0.00897	0.0155	CcSEcCtD
Rivastigmine—Dehydration—Metformin—polycystic ovary syndrome	0.00847	0.0147	CcSEcCtD
Rivastigmine—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.00841	0.0145	CcSEcCtD
Rivastigmine—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.00832	0.0144	CcSEcCtD
Rivastigmine—Breast disorder—Metformin—polycystic ovary syndrome	0.00823	0.0142	CcSEcCtD
Rivastigmine—Cramp muscle—Metformin—polycystic ovary syndrome	0.00821	0.0142	CcSEcCtD
Rivastigmine—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.00815	0.0141	CcSEcCtD
Rivastigmine—Pancreatitis—Metformin—polycystic ovary syndrome	0.00772	0.0134	CcSEcCtD
Rivastigmine—Angina pectoris—Metformin—polycystic ovary syndrome	0.00767	0.0133	CcSEcCtD
Rivastigmine—Sweating increased—Metformin—polycystic ovary syndrome	0.00767	0.0133	CcSEcCtD
Rivastigmine—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.00732	0.0127	CcSEcCtD
Rivastigmine—Drowsiness—Metformin—polycystic ovary syndrome	0.00702	0.0121	CcSEcCtD
Rivastigmine—Infestation NOS—Metformin—polycystic ovary syndrome	0.00702	0.0121	CcSEcCtD
Rivastigmine—Infestation—Metformin—polycystic ovary syndrome	0.00702	0.0121	CcSEcCtD
Rivastigmine—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00688	0.0119	CcSEcCtD
Rivastigmine—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00664	0.0115	CcSEcCtD
Rivastigmine—Bradycardia—Metformin—polycystic ovary syndrome	0.00642	0.0111	CcSEcCtD
Rivastigmine—Rhinitis—Metformin—polycystic ovary syndrome	0.00632	0.0109	CcSEcCtD
Rivastigmine—Hepatitis—Metformin—polycystic ovary syndrome	0.0063	0.0109	CcSEcCtD
Rivastigmine—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00627	0.0108	CcSEcCtD
Rivastigmine—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00621	0.0107	CcSEcCtD
Rivastigmine—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00619	0.0107	CcSEcCtD
Rivastigmine—Eye disorder—Metformin—polycystic ovary syndrome	0.00589	0.0102	CcSEcCtD
Rivastigmine—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00585	0.0101	CcSEcCtD
Rivastigmine—Flushing—Metformin—polycystic ovary syndrome	0.00585	0.0101	CcSEcCtD
Rivastigmine—Angiopathy—Metformin—polycystic ovary syndrome	0.00572	0.00989	CcSEcCtD
Rivastigmine—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00568	0.00982	CcSEcCtD
Rivastigmine—Chills—Metformin—polycystic ovary syndrome	0.00566	0.00978	CcSEcCtD
Rivastigmine—Malnutrition—Metformin—polycystic ovary syndrome	0.00549	0.00949	CcSEcCtD
Rivastigmine—Erythema—Metformin—polycystic ovary syndrome	0.00549	0.00949	CcSEcCtD
Rivastigmine—Flatulence—Metformin—polycystic ovary syndrome	0.00541	0.00935	CcSEcCtD
Rivastigmine—Dysgeusia—Metformin—polycystic ovary syndrome	0.00537	0.00929	CcSEcCtD
Rivastigmine—Muscle spasms—Metformin—polycystic ovary syndrome	0.00528	0.00912	CcSEcCtD
Rivastigmine—Vision blurred—Metformin—polycystic ovary syndrome	0.00517	0.00894	CcSEcCtD
Rivastigmine—Tremor—Metformin—polycystic ovary syndrome	0.00514	0.00889	CcSEcCtD
Rivastigmine—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00509	0.0088	CcSEcCtD
Rivastigmine—Malaise—Metformin—polycystic ovary syndrome	0.00495	0.00856	CcSEcCtD
Rivastigmine—Syncope—Metformin—polycystic ovary syndrome	0.00492	0.00851	CcSEcCtD
Rivastigmine—Palpitations—Metformin—polycystic ovary syndrome	0.00485	0.00838	CcSEcCtD
Rivastigmine—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00482	0.00834	CcSEcCtD
Rivastigmine—Hypertension—Metformin—polycystic ovary syndrome	0.00474	0.00819	CcSEcCtD
Rivastigmine—Chest pain—Metformin—polycystic ovary syndrome	0.00467	0.00808	CcSEcCtD
Rivastigmine—Myalgia—Metformin—polycystic ovary syndrome	0.00467	0.00808	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00464	0.00802	CcSEcCtD
Rivastigmine—Discomfort—Metformin—polycystic ovary syndrome	0.00462	0.00798	CcSEcCtD
Rivastigmine—Oedema—Metformin—polycystic ovary syndrome	0.00448	0.00774	CcSEcCtD
Rivastigmine—Infection—Metformin—polycystic ovary syndrome	0.00445	0.00769	CcSEcCtD
Rivastigmine—Shock—Metformin—polycystic ovary syndrome	0.00441	0.00762	CcSEcCtD
Rivastigmine—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00439	0.00759	CcSEcCtD
Rivastigmine—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00438	0.00758	CcSEcCtD
Rivastigmine—Skin disorder—Metformin—polycystic ovary syndrome	0.00435	0.00752	CcSEcCtD
Rivastigmine—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00433	0.00749	CcSEcCtD
Rivastigmine—Anorexia—Metformin—polycystic ovary syndrome	0.00427	0.00738	CcSEcCtD
Rivastigmine—Hypotension—Metformin—polycystic ovary syndrome	0.00418	0.00724	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00408	0.00706	CcSEcCtD
Rivastigmine—Paraesthesia—Metformin—polycystic ovary syndrome	0.00402	0.00695	CcSEcCtD
Rivastigmine—Dyspnoea—Metformin—polycystic ovary syndrome	0.00399	0.0069	CcSEcCtD
Rivastigmine—Somnolence—Metformin—polycystic ovary syndrome	0.00398	0.00688	CcSEcCtD
Rivastigmine—Dyspepsia—Metformin—polycystic ovary syndrome	0.00394	0.00682	CcSEcCtD
Rivastigmine—Decreased appetite—Metformin—polycystic ovary syndrome	0.00389	0.00673	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00387	0.00669	CcSEcCtD
Rivastigmine—Fatigue—Metformin—polycystic ovary syndrome	0.00386	0.00668	CcSEcCtD
Rivastigmine—Constipation—Metformin—polycystic ovary syndrome	0.00383	0.00662	CcSEcCtD
Rivastigmine—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00369	0.00638	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00366	0.00633	CcSEcCtD
Rivastigmine—Urticaria—Metformin—polycystic ovary syndrome	0.00356	0.00615	CcSEcCtD
Rivastigmine—Abdominal pain—Metformin—polycystic ovary syndrome	0.00354	0.00612	CcSEcCtD
Rivastigmine—Asthenia—Metformin—polycystic ovary syndrome	0.00321	0.00556	CcSEcCtD
Rivastigmine—Pruritus—Metformin—polycystic ovary syndrome	0.00317	0.00548	CcSEcCtD
Rivastigmine—Diarrhoea—Metformin—polycystic ovary syndrome	0.00306	0.0053	CcSEcCtD
Rivastigmine—Dizziness—Metformin—polycystic ovary syndrome	0.00296	0.00512	CcSEcCtD
Rivastigmine—Vomiting—Metformin—polycystic ovary syndrome	0.00285	0.00492	CcSEcCtD
Rivastigmine—Rash—Metformin—polycystic ovary syndrome	0.00282	0.00488	CcSEcCtD
Rivastigmine—Dermatitis—Metformin—polycystic ovary syndrome	0.00282	0.00488	CcSEcCtD
Rivastigmine—Headache—Metformin—polycystic ovary syndrome	0.00281	0.00485	CcSEcCtD
Rivastigmine—Nausea—Metformin—polycystic ovary syndrome	0.00266	0.0046	CcSEcCtD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.00131	0.0031	CbGpPWpGaD
Rivastigmine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.00129	0.00306	CbGpPWpGaD
Rivastigmine—BCHE—Peptide hormone metabolism—POMC—polycystic ovary syndrome	0.00128	0.00303	CbGpPWpGaD
Rivastigmine—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.00127	0.00302	CbGpPWpGaD
Rivastigmine—BCHE—Peptide hormone metabolism—INS—polycystic ovary syndrome	0.00127	0.00301	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—ADAMTS7—polycystic ovary syndrome	0.00126	0.00299	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—CPB2—polycystic ovary syndrome	0.00126	0.00299	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.00124	0.00294	CbGpPWpGaD
Rivastigmine—BCHE—Peptide hormone metabolism—IGF1—polycystic ovary syndrome	0.00123	0.00291	CbGpPWpGaD
Rivastigmine—BCHE—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.00122	0.00288	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	0.00121	0.00287	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.00118	0.0028	CbGpPWpGaD
Rivastigmine—ACHE—Neuronal System—CAMK2D—polycystic ovary syndrome	0.00118	0.0028	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.00117	0.00277	CbGpPWpGaD
Rivastigmine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.00115	0.00272	CbGpPWpGaD
Rivastigmine—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.00113	0.00268	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.00111	0.00262	CbGpPWpGaD
Rivastigmine—CYP3A4—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.00107	0.00255	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—INHBB—polycystic ovary syndrome	0.00107	0.00254	CbGpPWpGaD
Rivastigmine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.00107	0.00253	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.00105	0.0025	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—CAMK2D—polycystic ovary syndrome	0.00105	0.0025	CbGpPWpGaD
Rivastigmine—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.00105	0.0025	CbGpPWpGaD
Rivastigmine—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.00105	0.00248	CbGpPWpGaD
Rivastigmine—ACHE—Neuronal System—DLG4—polycystic ovary syndrome	0.00104	0.00248	CbGpPWpGaD
Rivastigmine—CYP3A4—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.00104	0.00248	CbGpPWpGaD
Rivastigmine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.00104	0.00247	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.00103	0.00245	CbGpPWpGaD
Rivastigmine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.00103	0.00243	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.00101	0.00238	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—NMNAT3—polycystic ovary syndrome	0.000961	0.00228	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—RPL37A—polycystic ovary syndrome	0.00096	0.00228	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—INHBB—polycystic ovary syndrome	0.000955	0.00227	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—DLG4—polycystic ovary syndrome	0.000932	0.00221	CbGpPWpGaD
Rivastigmine—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.00093	0.00221	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000916	0.00217	CbGpPWpGaD
Rivastigmine—CYP2D6—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000914	0.00217	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000897	0.00213	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000896	0.00212	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—LPCAT2—polycystic ovary syndrome	0.000879	0.00208	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—SUOX—polycystic ovary syndrome	0.000879	0.00208	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000868	0.00206	CbGpPWpGaD
Rivastigmine—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000864	0.00205	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—NMNAT3—polycystic ovary syndrome	0.000857	0.00203	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—RPL37A—polycystic ovary syndrome	0.000857	0.00203	CbGpPWpGaD
Rivastigmine—CYP2D6—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000853	0.00202	CbGpPWpGaD
Rivastigmine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000844	0.002	CbGpPWpGaD
Rivastigmine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000843	0.002	CbGpPWpGaD
Rivastigmine—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.000841	0.002	CbGpPWpGaD
Rivastigmine—CYP2D6—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000841	0.00199	CbGpPWpGaD
Rivastigmine—ACHE—ATF-2 transcription factor network—IL6—polycystic ovary syndrome	0.000833	0.00198	CbGpPWpGaD
Rivastigmine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000833	0.00197	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000818	0.00194	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—ISYNA1—polycystic ovary syndrome	0.000817	0.00194	CbGpPWpGaD
Rivastigmine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.00081	0.00192	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000799	0.0019	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000798	0.00189	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—LHB—polycystic ovary syndrome	0.000792	0.00188	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—SUOX—polycystic ovary syndrome	0.000784	0.00186	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—LPCAT2—polycystic ovary syndrome	0.000784	0.00186	CbGpPWpGaD
Rivastigmine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000776	0.00184	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000774	0.00184	CbGpPWpGaD
Rivastigmine—CYP2D6—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000755	0.00179	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000745	0.00177	CbGpPWpGaD
Rivastigmine—CYP2D6—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000745	0.00177	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—ISYNA1—polycystic ovary syndrome	0.000729	0.00173	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.00072	0.00171	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000712	0.00169	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—IGFBP1—polycystic ovary syndrome	0.000708	0.00168	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000707	0.00168	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—LHB—polycystic ovary syndrome	0.000706	0.00168	CbGpPWpGaD
Rivastigmine—CYP2D6—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000704	0.00167	CbGpPWpGaD
Rivastigmine—CYP2D6—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000702	0.00167	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—AKR1C2—polycystic ovary syndrome	0.000695	0.00165	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—TEAD2—polycystic ovary syndrome	0.000695	0.00165	CbGpPWpGaD
Rivastigmine—CYP2D6—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000693	0.00164	CbGpPWpGaD
Rivastigmine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000684	0.00162	CbGpPWpGaD
Rivastigmine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.00068	0.00161	CbGpPWpGaD
Rivastigmine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000671	0.00159	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000668	0.00158	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000665	0.00158	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000657	0.00156	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—IGFBP1—polycystic ovary syndrome	0.000632	0.0015	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000631	0.0015	CbGpPWpGaD
Rivastigmine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000629	0.00149	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.000629	0.00149	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—TEAD2—polycystic ovary syndrome	0.00062	0.00147	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—AKR1C2—polycystic ovary syndrome	0.00062	0.00147	CbGpPWpGaD
Rivastigmine—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000598	0.00142	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000596	0.00141	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—LMNA—polycystic ovary syndrome	0.000587	0.00139	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000587	0.00139	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PNPLA2—polycystic ovary syndrome	0.000582	0.00138	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000558	0.00132	CbGpPWpGaD
Rivastigmine—CYP2D6—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000556	0.00132	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—SRD5A1—polycystic ovary syndrome	0.000552	0.00131	CbGpPWpGaD
Rivastigmine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000551	0.00131	CbGpPWpGaD
Rivastigmine—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.00055	0.0013	CbGpPWpGaD
Rivastigmine—CYP2D6—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000548	0.0013	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—STAR—polycystic ovary syndrome	0.000526	0.00125	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—LMNA—polycystic ovary syndrome	0.000523	0.00124	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—GHRL—polycystic ovary syndrome	0.000523	0.00124	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.00052	0.00123	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PNPLA2—polycystic ovary syndrome	0.000519	0.00123	CbGpPWpGaD
Rivastigmine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000507	0.0012	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—ACE—polycystic ovary syndrome	0.000506	0.0012	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000494	0.00117	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—SRD5A1—polycystic ovary syndrome	0.000492	0.00117	CbGpPWpGaD
Rivastigmine—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000487	0.00116	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—TCF7L2—polycystic ovary syndrome	0.000486	0.00115	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.00047	0.00112	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—STAR—polycystic ovary syndrome	0.00047	0.00111	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—HMMR—polycystic ovary syndrome	0.000469	0.00111	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—GHRL—polycystic ovary syndrome	0.000466	0.00111	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000464	0.0011	CbGpPWpGaD
Rivastigmine—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.00046	0.00109	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000459	0.00109	CbGpPWpGaD
Rivastigmine—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000453	0.00107	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—ACE—polycystic ovary syndrome	0.000452	0.00107	CbGpPWpGaD
Rivastigmine—CYP2D6—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000448	0.00106	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—HSD3B1—polycystic ovary syndrome	0.000448	0.00106	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000442	0.00105	CbGpPWpGaD
Rivastigmine—CYP2D6—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000442	0.00105	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—TCF7L2—polycystic ovary syndrome	0.000434	0.00103	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000419	0.000995	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—HMMR—polycystic ovary syndrome	0.000419	0.000993	CbGpPWpGaD
Rivastigmine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000411	0.000975	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—LHB—polycystic ovary syndrome	0.000408	0.000968	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—HSD3B1—polycystic ovary syndrome	0.000399	0.000947	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—HSD3B2—polycystic ovary syndrome	0.000399	0.000946	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000395	0.000936	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—NMNAT3—polycystic ovary syndrome	0.000394	0.000935	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—AKR1C1—polycystic ovary syndrome	0.000386	0.000916	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000374	0.000887	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—LHB—polycystic ovary syndrome	0.000364	0.000864	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000363	0.000862	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—LPCAT2—polycystic ovary syndrome	0.00036	0.000855	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—SUOX—polycystic ovary syndrome	0.00036	0.000855	CbGpPWpGaD
Rivastigmine—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000358	0.00085	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—HSD3B2—polycystic ovary syndrome	0.000356	0.000844	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—SULT2A1—polycystic ovary syndrome	0.000356	0.000843	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—AKR1C1—polycystic ovary syndrome	0.000345	0.000817	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—RRM2—polycystic ovary syndrome	0.000344	0.000817	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ISYNA1—polycystic ovary syndrome	0.000335	0.000795	CbGpPWpGaD
Rivastigmine—CYP2D6—Biological oxidations—POMC—polycystic ovary syndrome	0.000334	0.000792	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—YAP1—polycystic ovary syndrome	0.000332	0.000787	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—NAMPT—polycystic ovary syndrome	0.000319	0.000756	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—SULT2A1—polycystic ovary syndrome	0.000317	0.000752	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000317	0.000752	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CYP11A1—polycystic ovary syndrome	0.000315	0.000747	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—LEP—polycystic ovary syndrome	0.000315	0.000746	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000313	0.000742	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—RRM2—polycystic ovary syndrome	0.000307	0.000729	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—AKR1C3—polycystic ovary syndrome	0.000297	0.000705	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—YAP1—polycystic ovary syndrome	0.000296	0.000702	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000293	0.000695	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CYP17A1—polycystic ovary syndrome	0.000293	0.000694	CbGpPWpGaD
Rivastigmine—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000289	0.000685	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—TEAD2—polycystic ovary syndrome	0.000285	0.000676	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—AKR1C2—polycystic ovary syndrome	0.000285	0.000676	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—NAMPT—polycystic ovary syndrome	0.000285	0.000675	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000283	0.000671	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CYP11A1—polycystic ovary syndrome	0.000281	0.000666	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—LEP—polycystic ovary syndrome	0.000281	0.000665	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000279	0.000662	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—POMC—polycystic ovary syndrome	0.00027	0.000641	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—INS—polycystic ovary syndrome	0.000269	0.000637	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—AKR1C3—polycystic ovary syndrome	0.000265	0.000629	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CYP17A1—polycystic ovary syndrome	0.000261	0.000619	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—IGF1—polycystic ovary syndrome	0.00026	0.000616	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000258	0.000611	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—TH—polycystic ovary syndrome	0.000253	0.000601	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—SLC2A4—polycystic ovary syndrome	0.000246	0.000584	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—POMC—polycystic ovary syndrome	0.000241	0.000572	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—INS—polycystic ovary syndrome	0.00024	0.000568	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	0.000239	0.000566	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.000236	0.000559	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.000236	0.000559	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—IGF1—polycystic ovary syndrome	0.000232	0.00055	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CYP19A1—polycystic ovary syndrome	0.000232	0.00055	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	0.000226	0.000537	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—TH—polycystic ovary syndrome	0.000226	0.000536	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—SLC2A4—polycystic ovary syndrome	0.00022	0.000521	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.000219	0.00052	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000218	0.000518	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	0.000216	0.000512	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—GNAS—polycystic ovary syndrome	0.000207	0.000491	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CYP19A1—polycystic ovary syndrome	0.000207	0.00049	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—NCOR1—polycystic ovary syndrome	0.000197	0.000467	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	0.000192	0.000456	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CYP1A1—polycystic ovary syndrome	0.000187	0.000443	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.000186	0.000442	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	0.000186	0.000442	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GNAS—polycystic ovary syndrome	0.000185	0.000438	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	0.000184	0.000435	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—NCOR1—polycystic ovary syndrome	0.000176	0.000417	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—MTHFR—polycystic ovary syndrome	0.000174	0.000413	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	0.000167	0.000397	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CYP1A1—polycystic ovary syndrome	0.000167	0.000395	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	0.000164	0.000388	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	0.000158	0.000376	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	0.000156	0.00037	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—MTHFR—polycystic ovary syndrome	0.000155	0.000368	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	0.000148	0.000351	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	0.000146	0.000346	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	0.000141	0.000335	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PPARG—polycystic ovary syndrome	0.000141	0.000335	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	0.000141	0.000335	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—POMC—polycystic ovary syndrome	0.000139	0.00033	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—INS—polycystic ovary syndrome	0.000138	0.000328	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	0.000136	0.000323	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	0.000131	0.00031	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	0.000129	0.000306	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PPARG—polycystic ovary syndrome	0.000126	0.000299	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	0.000126	0.000298	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—POMC—polycystic ovary syndrome	0.000124	0.000295	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—INS—polycystic ovary syndrome	0.000124	0.000293	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	0.000122	0.000289	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	0.00012	0.000285	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	0.00012	0.000285	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	0.000109	0.00026	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	0.000107	0.000254	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—TH—polycystic ovary syndrome	0.000104	0.000246	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	0.000104	0.000246	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	0.000101	0.00024	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	9.54e-05	0.000226	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	9.5e-05	0.000225	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	9.23e-05	0.000219	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	8.9e-05	0.000211	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	8.55e-05	0.000203	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	8.48e-05	0.000201	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	8.45e-05	0.0002	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	8.08e-05	0.000192	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	7.98e-05	0.000189	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	7.85e-05	0.000186	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	7.66e-05	0.000182	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	7.14e-05	0.000169	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—TH—polycystic ovary syndrome	6.79e-05	0.000161	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	6.61e-05	0.000157	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	6.21e-05	0.000147	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	5.79e-05	0.000137	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	5.71e-05	0.000135	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—INS—polycystic ovary syndrome	5.68e-05	0.000135	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	5.55e-05	0.000132	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	5.28e-05	0.000125	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	5.01e-05	0.000119	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	4.67e-05	0.000111	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	3.79e-05	8.98e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	3.73e-05	8.86e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—INS—polycystic ovary syndrome	3.71e-05	8.81e-05	CbGpPWpGaD
